The U.S. Food and Drug Administration (FDA) said on Thursday it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. "It's the first new pharmaceutical ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher ...
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...